Earn 5 CPD credits at free MIMS workshop on mental health and type 2 diabetes

Healthcare professionals are invited to attend a complimentary one-day MIMS Workshop in London on 5th December entitled 'Mental Health and Type 2 Diabetes on the Front Line', developed and fully funded by Janssen.

The workshop will cover the latest thinking in mental health and the management of type 2 diabetes, alongside instructive case presentations.

This one-day workshop is free for healthcare professionals to attend and provides the opportunity to earn 5 CPD credits toward revalidation.

Chaired by consultant endocrinologist Dr Marc Evans, the event features expert speakers Dr Adrian Heald, endocrinologist and diabetologist; Dr Richard Whale, principal lecturer, Brighton and Sussex Medical School; and Abby Maisey, RGN.

Following plenary sessions exploring patient and treatment choice and how to deliver value and outcomes in diabetes and mental health, the afternoon includes two practical workshops:

  • Parity of esteem in mental and physical health
  • Is there health without mental health?

The event will take place at the Royal College of General Practitioners, 30 Euston Square, London, NW1 2FB, on 5th December 2016.

To see the full agenda and register for your free place, please click here.

This promotional meeting has been developed and fully funded by Janssen.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

More from MIMS

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

Experts urge vitamin D supplementation and call for research into possible COVID-19 benefits
Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

New rapidly acting insulin launched

New rapidly acting insulin launched

Lyumjev is a new 'ultra rapidly acting' formulation...